Johnson & Johnson applies for Emergency Use Authorization of its single-dose Covid vaccine in India – ET HealthWorld

REUTERS/Vincent West/File Photo NEW DELHI: Johnson & Johnson has applied for Emergency Use Authorization (EUA) of its single-dose Covid-19 vaccine in India, the global healthcare major said on Friday. “On August 5, 2021 Johnson & Johnson Pvt Ltd applied for EUA of its single-dose Covid-19 vaccine to the government of India,” a Johnson & Johnson India spokesperson said in a statement. This is an important milestone that paves the way for bringing the company’s single-dose Covid-19 vaccine to the people of India, and the rest of the world, through a…

Read More